Home › Funds › Stonepine Capital Management, LLC › CABA

Stonepine Capital Management, LLC position in CABA

CABALETTA BIO INC · Health Care

Stonepine Capital Management, LLC reported holding 520,000 shares of CABA (CABALETTA BIO INC) in its Q3 2026 13F filing — a position valued at US$998K, representing 0.77% of its reported portfolio and ranking #31 among its reported holdings. Stonepine Capital Management, LLC has disclosed CABA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)520.00K sh
Reported value held$998.40K
Portfolio Weight0.77%
First reportedQ4 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's CABA position evolved

Stonepine Capital Management, LLC first disclosed a stake in CABA in Q4 2025 at 171,100 shares (US$375K). The position peaked in Q2 2026 at 917,100 shares, worth US$2.9M. Across 4 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 520,000 shares valued at US$998K — a reduction of -397,100 shares quarter over quarter.. Notable position changes include a 71% trim in Q1 2026 (shares rose 16% over the following quarter), a 1734% increase in Q2 2026 (shares fell 38% over the following quarter), a 43% trim in Q3 2026 (shares fell 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 171.10K $374.71K New
Q1 2026 50.00K $134.50K Reduce
Q2 2026 917.10K $2.85M Add
Q3 2026 520.00K $998.40K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CABA and 13F data

CABA (CABALETTA BIO INC) is a Health Care company. 36 other funds we track also report a position in CABA — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), Opaleye Management Inc. (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CABA

All CABA fund holders →

FAQ

How long has Stonepine Capital Management, LLC held CABA?

Stonepine Capital Management, LLC has disclosed CABA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Stonepine Capital Management, LLC's current position in CABA?

As of Q3 2026, Stonepine Capital Management, LLC holds 520.00K shares of CABA (CABALETTA BIO INC), valued at $998.40K, representing 0.77% of its reported portfolio and ranking #31.

Has Stonepine Capital Management, LLC been buying or selling CABA?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC reduced its position in CABA. The position peaked in Q2 2026 at 917.10K shares.

Which other funds hold CABA?

Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, Opaleye Management Inc., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.